Get the Stockscreener App
2.47
6.93%
0.16
After Hours:
2.48
0.010
+0.40%
Sangamo Therapeutics Inc Stock (SGMO) Forecast
The Sangamo Therapeutics Inc (SGMO) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.9775, representing a -19.94% decrease from the current price of $2.47. The highest analyst price target is $3.8725, and the lowest is $0.0825.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month SGMO Price Target
Average 2.9901
(+21.06% Upside)
Is Sangamo Therapeutics Inc (SGMO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 58.04 | Neutral |
| STOCH(9,6) | 65.61 | Neutral |
| STOCHRSI(14) | 47.35 | Neutral |
| MACD(12,26) | 0.1288 | Buy |
| ADX(14) | 23.37 | Neutral |
| William %R | -35.58 | Neutral |
| CCI(14) | 84.75 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.2445
Buy
|
2.3133
Buy
|
| MA20 |
2.1698
Buy
|
2.2129
Buy
|
| MA50 |
1.9422
Buy
|
1.9272
Buy
|
| MA100 |
1.3976
Buy
|
1.5576
Buy
|
| MA200 |
0.9806
Buy
|
1.2025
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, SGMO could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 0 signaling Sell signals and 6 Neutral signals. This might be a good time to open fresh positions on SGMO, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 58.04 indicates that SGMO is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 65.61 indicates that SGMO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 47.35 indicates that SGMO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 23.37 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 84.75 indicates that SGMO is still overbought but not to an extreme extent.
Long-term SGMO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Sangamo Therapeutics Inc financial reports and earnings history, Sangamo Therapeutics Inc (SGMO) stock could reach $9.148 by 2030, $5.7304 by 2040 and $16.70 by 2050. See the projected annual prices until 2050 of the Sangamo Therapeutics Inc stock below:
- Sangamo Therapeutics Inc (SGMO) is expected to reach an average price of $2.3574 in 2035, with a high prediction of $2.3925 and a low estimate of $2.3895. This indicates an $-4.56% rise from the last recorded price of $2.47.
- Sangamo Therapeutics Inc (SGMO) stock is projected to chart a bullish course in 2040, with an average price target of $5.7554, representing an $133.01% surge from its current level. The forecast ranges from a conservative $5.8071 to a sky-high $5.7304.
- Our analysts predict Sangamo Therapeutics Inc (SGMO) to jump 257.35% by 2045, soaring from $8.7932 to an average price of $8.8266, potentially reaching $8.5966. While $8.7932 is the low estimate, the potential upside is significant.
- Sangamo Therapeutics Inc (SGMO) stock is expected to climb by 2050, reaching an average of $15.95, a $545.91% jump from its current level. However, a wide range of estimates exists, with high and low targets of $16.70 and $16.88, respectively, highlighting the market's uncertainty.
Sangamo Therapeutics Inc Stock (SGMO) Year by Year Forecast
Sangamo Therapeutics Inc Stock (SGMO) Price Forecast for 2025
Sangamo Therapeutics Inc Stock (SGMO) is expected to reach an average price of $2.9901 in 2025, with a high prediction of $5.9644 and a low estimate of $0.0157. This indicates an +21.06% rise from the last recorded price of $2.47.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.1153 | $0.0825 | $3.8725 | -95.33% |
| February, 2025 | $0.8931 | $0.2092 | $0.7758 | -63.84% |
| March, 2025 | $0.2541 | $0.7814 | $1.0991 | -89.71% |
| April, 2025 | $1.6831 | $0.0903 | $1.3892 | -31.86% |
| May, 2025 | $0.2041 | $0.3958 | $1.1676 | -91.74% |
| June, 2025 | $2.3463 | $0.0157 | $2.6263 | -5.01% |
| July, 2025 | $1.264 | $1.149 | $4.3979 | -48.82% |
| August, 2025 | $3.2712 | $1.0096 | $3.6331 | +32.44% |
| September, 2025 | $5.0334 | $2.5729 | $5.6134 | +103.78% |
| October, 2025 | $2.8862 | $2.1962 | $5.9644 | +16.85% |
| November, 2025 | $2.4284 | $2.3884 | $4.0973 | -1.68% |
| December, 2025 | $3.4711 | $2.1489 | $4.68 | +40.53% |
Sangamo Therapeutics Inc Stock (SGMO) Price Forecast for 2026
The predicted value for Sangamo Therapeutics Inc (SGMO) in 2026 is set at an average of $7.6308. Estimates vary from a peak of $12.87 to a trough of $2.395, indicating an +208.94% surge from the present price of $2.47.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $3.3733 | $3.0033 | $5.6517 | +36.57% |
| February, 2026 | $7.6855 | $2.395 | $9.035 | +211.16% |
| March, 2026 | $9.2478 | $7.2561 | $12.87 | +274.40% |
| April, 2026 | $6.8605 | $6.5105 | $9.7883 | +177.75% |
| May, 2026 | $7.0027 | $4.2216 | $7.0327 | +183.51% |
| June, 2026 | $4.9149 | $4.7281 | $7.7333 | +98.98% |
| July, 2026 | $4.8977 | $3.8077 | $6.4866 | +98.29% |
| August, 2026 | $5.9299 | $4.5288 | $6.0999 | +140.08% |
| September, 2026 | $4.9626 | $4.7326 | $7.0912 | +100.92% |
| October, 2026 | $4.2048 | $3.5925 | $5.0632 | +70.24% |
| November, 2026 | $4.477 | $3.4569 | $4.7854 | +81.26% |
| December, 2026 | $3.7398 | $3.5587 | $4.9676 | +51.41% |
Sangamo Therapeutics Inc Stock (SGMO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Sangamo Therapeutics Inc (SGMO) is $3.2338, with a high forecast of $6.3931 and a low forecast of $0.0745. This indicates an +30.92% increase from the last price of $2.47.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.172 | $2.972 | $4.0303 | +28.42% |
| February, 2027 | $4.0342 | $2.7663 | $6.3931 | +63.33% |
| March, 2027 | $3.2869 | $2.1669 | $4.2963 | +33.07% |
| April, 2027 | $1.6391 | $1.2691 | $3.7975 | -33.64% |
| May, 2027 | $0.9213 | $0.6202 | $1.5797 | -62.70% |
| June, 2027 | $1.0041 | $0.583 | $1.6619 | -59.35% |
| July, 2027 | $1.4463 | $0.6752 | $1.9763 | -41.45% |
| August, 2027 | $0.4585 | $0.3985 | $2.0074 | -81.44% |
| September, 2027 | $0.4088 | $0.191 | $0.629 | -83.45% |
| October, 2027 | $0.3866 | $0.3771 | $0.3382 | -84.35% |
| November, 2027 | $0.7856 | $0.0745 | $0.9649 | -68.19% |
| December, 2027 | $2.6384 | $0.3362 | $2.6984 | +6.82% |
Sangamo Therapeutics Inc Stock (SGMO) Price Forecast for 2028
In 2028, Sangamo Therapeutics Inc (SGMO) is projected to reach an average price of $1.4142, with a high projection of $2.759 and a low estimate of $0.0695. This indicates an -42.74% fall from the last price of $2.47.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.9606 | $1.5101 | $2.759 | -20.62% |
| February, 2028 | $1.4528 | $1.3053 | $2.3412 | -41.18% |
| March, 2028 | $1.0956 | $0.8162 | $1.6534 | -55.65% |
| April, 2028 | $0.3878 | $0.0817 | $1.2461 | -84.30% |
| May, 2028 | $0.0495 | $0.0695 | $0.63 | -98.00% |
| June, 2028 | $0.5427 | $0.1316 | $0.8297 | -78.03% |
| July, 2028 | $0.2749 | $0.1849 | $0.9244 | -88.87% |
| August, 2028 | $0.3623 | $0.0766 | $0.601 | -85.33% |
| September, 2028 | $0.8701 | $0.6318 | $0.7301 | -64.77% |
| October, 2028 | $1.0379 | $0.929 | $0.8479 | -57.98% |
| November, 2028 | $1.0752 | $1.0463 | $1.0652 | -56.47% |
| December, 2028 | $0.803 | $0.973 | $0.8746 | -67.49% |
Sangamo Therapeutics Inc Stock (SGMO) Price Forecast for 2029
The 2029 price forecast for Sangamo Therapeutics Inc Stock (SGMO) is $3.5077 on average, with a high prediction of $7.0024 and a low estimate of $0.013. This represents an +42.01% increase from the previous price of $2.47.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.6352 | $0.6452 | $0.6774 | -74.28% |
| February, 2029 | $1.0579 | $0.7397 | $0.8605 | -57.17% |
| March, 2029 | $0.7065 | $0.8161 | $0.8199 | -71.40% |
| April, 2029 | $1.0236 | $0.9128 | $0.9987 | -58.56% |
| May, 2029 | $1.1338 | $1.0168 | $0.9828 | -54.10% |
| June, 2029 | $0.8546 | $0.8787 | $0.9783 | -65.40% |
| July, 2029 | $0.6432 | $0.7914 | $0.776 | -73.96% |
| August, 2029 | $0.5767 | $0.6224 | $0.5806 | -76.65% |
| September, 2029 | $0.2185 | $0.1085 | $0.5379 | -91.15% |
| October, 2029 | $0.0558 | $0.013 | $0.439 | -97.74% |
| November, 2029 | $0.125 | $0.1372 | $0.0729 | -94.94% |
| December, 2029 | $8.9524 | $0.0286 | $7.0024 | +262.45% |
Sangamo Therapeutics Inc Stock (SGMO) Price Forecast for 2030
Sangamo Therapeutics Inc Stock (SGMO) is expected to reach an average price of $7.8938 in 2030, with a high forecast of $9.3884 and a low forecast of $6.3992. This signifies an +219.59% surge from the last price of $2.47.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $9.3069 | $9.5313 | $9.148 | +276.80% |
| February, 2030 | $6.6424 | $7.8925 | $8.4408 | +168.92% |
| March, 2030 | $6.7331 | $6.3992 | $6.2214 | +172.59% |
| April, 2030 | $7.0637 | $6.9748 | $6.6437 | +185.98% |
| May, 2030 | $8.5532 | $7.2704 | $8.0382 | +246.28% |
| June, 2030 | $8.4638 | $9.0883 | $8.7799 | +242.66% |
| July, 2030 | $7.2633 | $7.8294 | $7.8027 | +194.06% |
| August, 2030 | $8.4339 | $6.5261 | $8.1639 | +241.45% |
| September, 2030 | $8.2195 | $8.4828 | $8.2617 | +232.77% |
| October, 2030 | $8.769 | $8.4834 | $8.8562 | +255.02% |
| November, 2030 | $9.7995 | $8.1507 | $8.6129 | +296.74% |
| December, 2030 | $9.3651 | $9.7212 | $9.3884 | +279.16% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):